{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:50:32Z","timestamp":1775555432719,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T00:00:00Z","timestamp":1443398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00296-015-3366-2","type":"journal-article","created":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T07:32:22Z","timestamp":1443425542000},"page":"1913-1916","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Infliximab as a treatment option for patients with rheumatoid arthritis and primary biliary cirrhosis"],"prefix":"10.1007","volume":"35","author":[{"given":"Despoina","family":"Dimopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Dimitroulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Akriviadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Garyfallos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,28]]},"reference":[{"key":"3366_CR1","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.3748\/wjg.v21.i25.7683","volume":"21","author":"VI Reshetnyak","year":"2015","unstructured":"Reshetnyak VI (2015) Primary biliary cirrhosis: clinical and laboratory criteria for its diagnosis. World J Gastroenterol 21:7683\u20137708","journal-title":"World J Gastroenterol"},{"key":"3366_CR2","first-page":"926","volume":"7","author":"T Purohit","year":"2015","unstructured":"Purohit T, Cappell M (2015) Primary biliary cirrhosis: pathophysiology, clinical presentation and therapy. World J Gastroenterol 7:926\u2013941","journal-title":"World J Gastroenterol"},{"key":"3366_CR3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2011.11.005","volume":"39","author":"C Selmi","year":"2012","unstructured":"Selmi C, Meroni PL, Gershwin ME (2012) Primary biliary cirrhosis and Sj\u00f6gren\u2019s syndrome: autoimmune epithelitis. J Autoimmun 39:34\u201342","journal-title":"J Autoimmun"},{"key":"3366_CR4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jaad.2007.07.031","volume":"58","author":"S Kishor","year":"2008","unstructured":"Kishor S, Turner ML, Borg BB, Kleiner DE, Cowen EW (2008) Cutaneous sarcoidosis and primary biliary cirrhosis: a chance association or related diseases? J Am Acad Dermatol 58:326\u2013335","journal-title":"J Am Acad Dermatol"},{"key":"3366_CR5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jbspin.2006.06.012","volume":"74","author":"C Caramella","year":"2007","unstructured":"Caramella C, Avouac J, Sogni P et al (2007) Association between rheumatoid arthritis and primary biliary cirrhosis. Joint Bone Spine 74:279\u2013281","journal-title":"Joint Bone Spine"},{"key":"3366_CR6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/01.rhu.0000099623.30805.2f","volume":"9","author":"JL Siegel","year":"2003","unstructured":"Siegel JL, Luthra H, Donlinger J et al (2003) Association of primary biliary cirrhosis and rheumatoid arthritis. Clin Rheumatol 9:340\u2013343","journal-title":"Clin Rheumatol"},{"key":"3366_CR7","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.3390\/ijms16036432","volume":"16","author":"Jun Gao","year":"2015","unstructured":"Gao Jun, Qiao Liang, Wang Bingyuan (2015) Primary biliary cirrhosis is a generalized autoimmune epithelitis. Int J Mol Sci 16:6432\u20136446","journal-title":"Int J Mol Sci"},{"key":"3366_CR8","doi-asserted-by":"crossref","first-page":"713728","DOI":"10.1155\/2015\/713728","volume":"2015","author":"T Shizuma","year":"2015","unstructured":"Shizuma T (2015) Clinical characteristics of concomitant systemic lupus erythematosus and primary biliary cirrhosis: a literature review. J Immunol Res 2015:713728","journal-title":"J Immunol Res"},{"key":"3366_CR9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00281-009-0164-5","volume":"31","author":"S Hohenester","year":"2009","unstructured":"Hohenester S, Oude-Elferink R (2009) Primary biliary cirrhosis. Semin Immunopathol 31:283\u2013307","journal-title":"Semin Immunopathol"},{"key":"3366_CR10","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2013","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2013) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417","journal-title":"Rheumatol Int"},{"key":"3366_CR11","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, SIlman A et al (2010) 2010 rheumatoid arthritis classification criteria: an America College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580\u20131588","journal-title":"Ann Rheum Dis"},{"key":"3366_CR12","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581","journal-title":"Arthritis Rheum"},{"key":"3366_CR13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","volume":"379","author":"J Ludwig","year":"1978","unstructured":"Ludwig J, Dickson ER, McDonald GS (1978) Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 379:103\u2013112","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"3366_CR14","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin M (2005) Primary biliary cirrhosis. N Engl J Med 353:1261\u20131273","journal-title":"N Engl J Med"},{"key":"3366_CR15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/01.rhu.0000099623.30805.2f","volume":"9","author":"JL Siegel","year":"2003","unstructured":"Siegel JL, Luthra H, Donlinger J, Angulo P, Lindor K (2003) Association of primary biliary cirrhosis and rheumatoid arthritis. J Clin Rheumatol 9:340\u2013343","journal-title":"J Clin Rheumatol"},{"key":"3366_CR16","first-page":"391567","volume":"2012","author":"DS Smyk","year":"2012","unstructured":"Smyk DS, Bogdanos DP, Mytilinaiou MG, Burroughs AK, Rigopoulou EI (2012) Rheumatoid arthritis and primary biliary cirrhosis: cause, consequence, or coincidence? Arthritis 2012:391567","journal-title":"Arthritis"},{"key":"3366_CR17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jbspin.2007.03.003","volume":"75","author":"A Spadaro","year":"2008","unstructured":"Spadaro A, Scrivo Riccieri V, Valesini G (2008) Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis. Joint Bone Spine 75:87\u201389","journal-title":"Joint Bone Spine"},{"key":"3366_CR18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jbspin.2008.05.004","volume":"76","author":"A Ogata","year":"2009","unstructured":"Ogata A, Terabe F, Nakanishi K et al (2009) Etanercept improved primary biliary cirrhosis associated with rheumatoid arthritis. Lett Ed Joint Bone Spine 76:105\u2013107","journal-title":"Lett Ed Joint Bone Spine"},{"key":"3366_CR19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10067-005-0169-y","volume":"26","author":"GJ Tobon","year":"2007","unstructured":"Tobon GJ, Ca\u00f1as C, Jaller JJ et al (2007) Serious liver disease induced by infliximab. Clin Rheumatol 26:578\u2013581","journal-title":"Clin Rheumatol"},{"key":"3366_CR20","doi-asserted-by":"crossref","first-page":"84e6","DOI":"10.4065\/76.1.84","volume":"76","author":"VV Menghini","year":"2001","unstructured":"Menghini VV, Arora AS (2001) Infliximab-associated reversible cholestatic liver disease. Mayo Clin Proc 76:84e6","journal-title":"Mayo Clin Proc"},{"key":"3366_CR21","first-page":"386328","volume":"2014","author":"E Saito","year":"2014","unstructured":"Saito E, Sato S, Nogi S et al (2014) A case of rheumatoid arthritis and limited systemic sclerosis overlap successfully treated with tocilizumab for arthritis and concomitant generalized lymphadenopathy and primary biliary cirrhosis. Case Rep Rheumatol 2014:386328","journal-title":"Case Rep Rheumatol"},{"key":"3366_CR22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/rheumatology\/kep354","volume":"49","author":"S Scarpato","year":"2010","unstructured":"Scarpato S, Antivalle M, Favalli EG et al (2010) Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study). Rheumatology 49:289\u2013294","journal-title":"Rheumatology"},{"key":"3366_CR23","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0168-8278(00)80213-5","volume":"32","author":"K Agarwal","year":"2000","unstructured":"Agarwal K, Jones DE, Daly AK et al (2000) CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 32:538\u2013541","journal-title":"J Hepatol"},{"key":"3366_CR24","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","volume":"423","author":"H Ueda","year":"2003","unstructured":"Ueda H, Howson JM, Esposito L et al (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506\u2013511","journal-title":"Nature"},{"key":"3366_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1677\/jme.0.0310021","volume":"31","author":"DA Chistiakov","year":"2003","unstructured":"Chistiakov DA, Turakulov RI (2003) CTLA-4 and its role in autoimmune thyroid disease. J Mol Endocrinol 31:21\u201336","journal-title":"J Mol Endocrinol"},{"key":"3366_CR26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.smim.2006.03.011","volume":"18","author":"S Krishnan","year":"2006","unstructured":"Krishnan S, Chowdhury B, Tsokos GC (2006) Autoimmunity in systemic lupus erythematosus: integrating genes and biology. Semin Immunol 18:230\u2013243","journal-title":"Semin Immunol"},{"key":"3366_CR27","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1089-3261(03)00095-3","volume":"7","author":"DE Jones","year":"2003","unstructured":"Jones DE, Donaldson PT (2003) Genetic factors in the pathogenesis of primary biliary cirrhosis. Clin Liver Dis 7:841\u2013864","journal-title":"Clin Liver Dis"},{"key":"3366_CR28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.gene.6364248","volume":"6","author":"C Selmi","year":"2005","unstructured":"Selmi C, Invernizzi P, Zuin M et al (2005) Genes and (auto) immunity in primary biliary cirrhosis. Genes Immun 6:543\u2013556","journal-title":"Genes Immun"},{"key":"3366_CR29","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2008.07.027","volume":"49","author":"R Poupon","year":"2008","unstructured":"Poupon R, Ping C, Chr\u00e9tien Y et al (2008) Genetic factors of susceptibility and of severity in primary biliary cirrhosis. J Hepatol 49:1038\u20131045","journal-title":"J Hepatol"},{"key":"3366_CR30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1440-1746.2002.02672.x","volume":"17","author":"M Neuman","year":"2002","unstructured":"Neuman M, Angulo P, Malkiewicz I et al (2002) Tumor necrosis factor-\u03b1 and transforming growth factor-\u03b2 reflect severity of liver damage in primary biliary cirrhosis. J Gastroenterol Hepatol 17:196\u2013202","journal-title":"J Gastroenterol Hepatol"},{"key":"3366_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10238-008-0149-z","volume":"8","author":"Y Liang","year":"2008","unstructured":"Liang Y, Yang Z, Li C et al (2008) Characterisation of TNF-related apoptosis-inducing ligand in peripheral blood in patients with primary biliary cirrhosis. Clin Exp Med 8:1\u20137","journal-title":"Clin Exp Med"},{"key":"3366_CR32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1074\/jbc.M309476200","volume":"279","author":"H Higuchi","year":"2004","unstructured":"Higuchi H, Grambihler A, Canbay A et al (2004) Bile acids upregulate death receptor 5\/TRAIL-receptor 2 expression via a c-N-terminal kinase-dependent pathway involving Sp1. J Biol Chem 279:51\u201360","journal-title":"J Biol Chem"},{"key":"3366_CR33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaut.2007.02.003","volume":"28","author":"R Rieger","year":"2007","unstructured":"Rieger R, Gershwin ME (2007) The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 28:76\u201384","journal-title":"J Autoimmun"},{"key":"3366_CR34","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/j.gastro.2008.08.020","volume":"135","author":"P Invernizzi","year":"2008","unstructured":"Invernizzi P, Gershwin ME (2008) The genetic basis of primary biliary cirrhosis: premises, not promises. Gastroenterology 135:1044\u20131104","journal-title":"Gastroenterology"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3366-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-015-3366-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3366-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T01:37:42Z","timestamp":1567215462000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-015-3366-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,28]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["3366"],"URL":"https:\/\/doi.org\/10.1007\/s00296-015-3366-2","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,28]]}}}